In conclusion, NRF1 relieved motor dysfunction and dopamine neuron degeneration in MPTP‐induced PD mice by increasing m6A modification of GLRX mRNA through elevation of METTL3 transcription. The gene discussed is GLRX; the disease is Parkinson disease.